Med-Chemist

Med-Chemist : "Quintessential Medicinal Chemistry"

Showing posts with label Endogenous Hypercortisolemia. Show all posts
Showing posts with label Endogenous Hypercortisolemia. Show all posts
Thursday, March 10, 2022

FDA Approves Recorlev (levoketoconazole) for the Treatment of Endogenous Hypercortisolemia in Adult Patients With Cushing’s Syndrome

›
Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), announce  the U.S. Food and Drug Administration (FDA) approval of Recorlev ®  (levoketoconazo...
›
Home
View web version

Contributors

  • Dr. Umesh..
  • https://www.med-chemist.com
Powered by Blogger.